2021 Symposium
|
10th Anniversary Translational Oncology SymposiumA decade of fostering collaborations, fueling innovation & saving lives: MCC Translational Oncology Symposium unites academic and industrial communities to deliver innovative, life-saving cancer therapies, tools and diagnosticsWe would like to thank all speakers and attendees for such a successful symposium. It was such an impressive turnout of distinguished colleagues from the academic and private sectors, convening to share ideas and discuss opportunities to work more closely together, truly indicating a widespread commitment to closing the gap between the discovery and development of new therapies to help patient. We feel this was our most successful event yet, celebrating a decade of gathering the elite minds in oncology research. PressSan Diego ABC 10 News reporter Michael Chen interviewed San Diego resident Heather Clark, a patient of Moores Cancer Center, along with Ida Deichaite, Director of Industry Relations & Symposium Organizer, in a video report about the I-SPY Clinical Trial and Symposium. The I-SPY Clinical Trial is lead by Symposium Keynote Speaker and Principle Investigator Laura Esserman, MD, MBA. For the video, see here.Featured TalksPlease enjoy the featured talks below from our recent symposium. Thank you! Please note: These videos are for private viewing only. Any unintended use of the videos without consent is prohibited. Development of BMN 673, a potent and selective poly-(ADP-ribose)polymerase (PARP)-1/2 inhibitor in selected patients with homologous recombination defectsGilles Gallant, BPharm PhD BioMarin Pharmaceutical Inc. Translational considerations for a novel inhibitor of p97 for the treatment of myeloma and solid tumorsLaura Shawver, PhD Cleave Biosciences, Inc. Zeroing in an oncogenic driver: The Rapid Evolution of Targeted Therapies for Anaplastic Lymphoma Kinase-Positive Lung CancerValeria Fantin, PhD Pfizer Reversing Cancer Stemness and Drug ResistanceDavid Cheresh, PhD Moores Cancer Center Development of Highly Active Cancer Stem Cell TherapyDennis Carson, MD Moores Cancer Center Stem cell principles applied to colon cancer: tracing clonal dynamics and targeting self-renewalAntonija Kreso, PhD University of Toronto Malignant Reprogramming and Cancer Stem CellsCatriona Jamieson, MD, PhD Moores Cancer Center Will 5 billion be approved by California voters for CIRM in 2016?Robert Klein Klein Financial Corporation WelcomePradeep Khosla UC San Diego SF3B1 mutations in different cancer types cause recognition of sterically hindered cryptic splice-sites downstream of the branch pointKelly Frazer, PhD Moores Cancer Center Omics as a Disruptive Technology: Implications for Cancer TherapyRazelle Kurzrock, MD Moores Cancer Center Precision Oncology Strategies: Targeting Genetic and Epigenetic Drivers in Cancer Drug DevelopmentJames Christensen, PhD Mirati Therapeutics A novel isoform of the RON kinase transforms pancreatic duct epithelial cellsAndrew Lowy, MD, FACS Moores Cancer Center Preclinical and early clinical activity of STAT3RX/AZD9150, A NEXT GENERATION ANTISENSE OLIGONUCLEOTIDE TARGETING STAT3Robert MacLeod, PhD Isis Pharmaceuticals Nuclear Receptors: Integrating Molecular Endocrinology and Drug DiscoveryRichard Heyman, PhD Seragon Pharmaceuticals Androgen Receptor Signaling Axis on CRPC – The A to Z in Drug DevelopmentNamPhuong Tran, MD Janssen R&D Panel Discussion: Funding InnovationModerator: Chris Cain, PhD, SciBX:Science-Business eXchange, BioCentury Publications Panel Members: Michael Flaschen, Johnson & Johnson Innovation Richard Heyman, PhD, Seragon Pharmaceuticals Catriona Jamieson, MD, PhD, Moores Cancer Center Jay Lichter, PhD, Avalon Ventures Greg Simon, Poliwogg “When you go to an international cancer symposium with 30,000 people, it’s hard to get to the real champion of a project and get their individualized attention. The Moores Cancer Center Translational Oncology Symposium is much more intimate. Industry and academia are on equal footing and there are plenty of opportunities for informal discussions when a lot of synergies develop and collaborations begin or grow.”- Catriona Jamieson, Ph.D., M.D.,
|
Symposium Organizers:Scott Lippman, MD Symposium Chair:David Cheresh, PhD |
Ida Deichaite, PhD Symposium Co-Chair:Catriona Jamieson, MD, PhD |